Nandan Kulkarni

Stock Analyst at Bernstein

(1.50)
# 3,612
Out of 4,670 analysts
2
Total ratings
50%
Success rate
1.4%
Average return

Stocks Rated by Nandan Kulkarni

Mankind Pharma Limited
Jul 31, 2026
Maintained: Sell
Price Target: ₹2,057
Current: ₹2,384
Upside: -13.72%